 WALTHAM, Mass.-- BUSINESS WIRE --ImmunoGen, Inc. Nasdaq: IMGN, a leader in the expanding field of antibody-drug conjugates ADCs for the treatment of cancer, today announced that Mark Enyedy, President and CEO, will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The presentation is scheduled for 3:45pm PT 6:45pm ET on January 10, 2023. 